HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hiromichi Ito Selected Research

Fibronectins (Fibronectin)

5/2004Fibronectin-induced COX-2 mediates MMP-2 expression and invasiveness of rhabdomyosarcoma.
4/2004c-Src-dependent cross-talk between CEACAM6 and alphavbeta3 integrin enhances pancreatic adenocarcinoma cell adhesion to extracellular matrix components.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hiromichi Ito Research Topics

Disease

60Neoplasms (Cancer)
12/2023 - 09/2003
40Pancreatic Neoplasms (Pancreatic Cancer)
01/2024 - 08/2003
30Neoplasm Metastasis (Metastasis)
02/2024 - 02/2004
24Adenocarcinoma
08/2023 - 09/2003
6Colorectal Neoplasms (Colorectal Cancer)
10/2023 - 02/2012
4Sinistral Portal Hypertension
10/2021 - 01/2019
3Pancreatic Fistula (Pancreatic Fistulas)
09/2023 - 10/2018
3Brain Diseases (Brain Disorder)
11/2019 - 07/2004
3Seizures (Absence Seizure)
11/2019 - 10/2004
3Autism Spectrum Disorder
01/2017 - 02/2013
3Pancreatitis
12/2008 - 09/2005
2Hemorrhage
04/2023 - 01/2021
2Head and Neck Neoplasms (Head and Neck Cancer)
01/2023 - 02/2022
2Colonic Neoplasms (Colon Cancer)
12/2022 - 01/2021
2Diarrhea
01/2022 - 01/2019
2Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
01/2021 - 08/2006
2Colic (Abdominal Cramps)
01/2019 - 01/2017
2Pulmonary Emphysema
03/2013 - 03/2013
2Pathologic Constriction (Stenosis)
05/2012 - 01/2011
2Carcinoma (Carcinomatosis)
03/2011 - 10/2009
2Chronic Pancreatitis
01/2011 - 10/2010
2Epilepsy (Aura)
10/2005 - 10/2004
1Chylous Ascites
02/2024
1Thrombosis (Thrombus)
01/2024
1Margins of Excision
11/2023
1Ischemia
10/2023
1Sarcopenia
09/2023
1Infections
04/2023
1Duodenal Neoplasms (Duodenal Cancer)
01/2023
1Residual Neoplasm
12/2022
1Mucinous Adenocarcinoma (Mucinous Carcinoma)
05/2022
1Hemangiosarcoma (Angiosarcoma)
04/2022
1Stomach Neoplasms (Stomach Cancer)
02/2022
1Portal Hypertension
10/2021
1Liposarcoma
06/2021
1Hemangioma (Angioma)
06/2021

Drug/Important Bio-Agent (IBA)

17GemcitabineFDA Link
08/2023 - 11/2003
8Carcinoembryonic AntigenIBA
10/2023 - 01/2004
7Small Interfering RNA (siRNA)IBA
08/2016 - 02/2004
5130-nm albumin-bound paclitaxelIBA
01/2023 - 02/2021
5Protons (Proton)IBA
01/2017 - 07/2008
5Messenger RNA (mRNA)IBA
01/2016 - 10/2009
5Cell Adhesion MoleculesIBA
10/2004 - 01/2004
4Biomarkers (Surrogate Marker)IBA
11/2023 - 02/2012
4Ribonucleotide Reductases (Ribonucleotide Reductase)IBA
03/2023 - 01/2004
4Immunoglobulins (Immunoglobulin)IBA
07/2004 - 08/2003
3Focal Adhesion Protein-Tyrosine KinasesIBA
01/2023 - 11/2003
3folfirinoxIBA
08/2022 - 04/2021
3Phosphotransferases (Kinase)IBA
08/2015 - 12/2003
3Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
08/2015 - 05/2012
3SteroidsIBA
05/2013 - 10/2005
2Tumor Biomarkers (Tumor Markers)IBA
11/2023 - 11/2023
2Indocyanine Green (Cardio-Green)FDA LinkGeneric
10/2023 - 12/2017
2N-acetyltalosaminuronic acid (NAT)IBA
10/2023 - 02/2021
2Insulin-Like Growth Factor I (IGF-1)IBA
08/2023 - 07/2004
2Glucose (Dextrose)FDA LinkGeneric
01/2023 - 01/2004
2AntidiarrhealsIBA
01/2022 - 01/2019
2Opioid Analgesics (Opioids)IBA
01/2022 - 01/2019
2Histones (Histone)IBA
12/2021 - 08/2016
2Proteins (Proteins, Gene)FDA Link
12/2021 - 05/2004
2Indicators and Reagents (Reagents)IBA
01/2021 - 02/2020
2Zonisamide (Zonegran)FDA LinkGeneric
11/2019 - 07/2007
2Valproic Acid (Depakote)FDA LinkGeneric
11/2019 - 08/2006
2DNA (Deoxyribonucleic Acid)IBA
08/2016 - 08/2015
2RNA (Ribonucleic Acid)IBA
01/2013 - 02/2012
2N-acetylaspartate (N-acetyl aspartate)IBA
04/2011 - 07/2008
2GhrelinIBA
03/2008 - 09/2003
2AutoantibodiesIBA
10/2005 - 08/2003
2Cyclooxygenase 2 (Cyclooxygenase-2)IBA
10/2004 - 05/2004
2ProstaglandinsIBA
10/2004 - 05/2004
2Prostaglandins EIBA
10/2004 - 05/2004
2Glycosylphosphatidylinositols (Glycosyl-Phosphatidylinositol)IBA
07/2004 - 05/2004
2Peptides (Polypeptides)IBA
07/2004 - 09/2003
2Fibronectins (Fibronectin)IBA
05/2004 - 04/2004
2src-Family KinasesIBA
04/2004 - 08/2003
1N-succinimidyl 3-(2-pyridyldithio)propionate (SPDP)IBA
10/2023
1C-Reactive ProteinIBA
04/2023
1AmylasesFDA Link
04/2023
1Insulin (Novolin)FDA Link
12/2022
1Paclitaxel (Taxol)FDA LinkGeneric
04/2022
1AlbuminsIBA
01/2022

Therapy/Procedure

20Drug Therapy (Chemotherapy)
11/2023 - 12/2003
18Pancreaticoduodenectomy
02/2024 - 10/2010
17Therapeutics
12/2022 - 11/2003
15Hepatectomy
02/2024 - 03/2010
11Neoadjuvant Therapy
10/2023 - 12/2015
7Pancreatectomy
12/2023 - 01/2017
5Ligation
02/2024 - 08/2004
4Adjuvant Chemotherapy
11/2023 - 01/2019
4Cholecystectomy
08/2011 - 04/2008
3Lymph Node Excision (Lymph Node Dissection)
11/2023 - 10/2017
2Stents
11/2021 - 05/2012
2Synchrotrons
09/2014 - 03/2013
2Length of Stay
12/2009 - 09/2005
1Enteral Nutrition (Feeding, Tube)
02/2024
1Metastasectomy
01/2024
1Glycemic Control
12/2022
1Laparotomy
06/2022
1Transjugular Intrahepatic Portasystemic Shunt
10/2021
1Laparoscopic Cholecystectomy
06/2021